Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Jackson

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Antimicrobial Agents|April 5, 2026
Mobile colistin resistance in New Zealand without local agricultural colistin use: genomic insights into mcr-carrying plasmids and their global context, 1984-2024Jenny Szeto, Rhys T White, Hermes Perez, et al.
Hepatology Communications|May 2, 2024
Liver-specific mitochondrial amidoxime-reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse modelsYuanjun Guo, Zhengyu Gao, Edward L LaGory, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 22, 2025
Integration of bla<sub>OXA-48</sub> into a Col156 plasmid drove a carbapenem-resistant Escherichia coli ST131 outbreak in New Zealand: Global genomic evidence for the gene's multilayered disseminationRhys T White, Craig N Thornley, Max Bloomfield, et al.
Journal of Lipid Research|April 23, 2016
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
The Science of the Total Environment|August 15, 2018
Scoping studies to establish the capability and utility of a real-time bioaerosol sensor to characterise emissions from environmental sourcesZaheer Ahmad Nasir, Enda Hayes, Ben Williams, et al.
Journal of Lipid Research|June 13, 2026
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
Journal of Lipid Research|September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoEBrandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Clinical Investigation|November 19, 2020
The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injuryPaul F Lebeau, Hanny Wassef, Jae Hyun Byun, et al.
Microbiology (Reading, England)|May 15, 2025
Promoting global collaboration to improve bioaerosol exposure assessment and understanding of associated health impacts: outcomes from a series of workshopsEmma L Marczylo, Simon Jackson, Christine Bell, et al.
The Journal of Animal Ecology|August 18, 2022
Signatures of increasing environmental stress in bumblebee wings over the past century: Insights from museum specimensAndres N Arce, Aoife Cantwell-Jones, Michael Tansley, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Antimicrobial Agents|April 5, 2026
Mobile colistin resistance in New Zealand without local agricultural colistin use: genomic insights into mcr-carrying plasmids and their global context, 1984-2024Jenny Szeto, Rhys T White, Hermes Perez, et al.
Hepatology Communications|May 2, 2024
Liver-specific mitochondrial amidoxime-reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse modelsYuanjun Guo, Zhengyu Gao, Edward L LaGory, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 22, 2025
Integration of bla<sub>OXA-48</sub> into a Col156 plasmid drove a carbapenem-resistant Escherichia coli ST131 outbreak in New Zealand: Global genomic evidence for the gene's multilayered disseminationRhys T White, Craig N Thornley, Max Bloomfield, et al.
Journal of Lipid Research|April 23, 2016
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
The Science of the Total Environment|August 15, 2018
Scoping studies to establish the capability and utility of a real-time bioaerosol sensor to characterise emissions from environmental sourcesZaheer Ahmad Nasir, Enda Hayes, Ben Williams, et al.
Journal of Lipid Research|June 13, 2026
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's roleFrederick J Raal, Robert P Giugliano, Marc S Sabatine, et al.
Journal of Lipid Research|September 27, 2014
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoEBrandon Ason, José W A van der Hoorn, Joyce Chan, et al.
The Journal of Clinical Investigation|November 19, 2020
The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injuryPaul F Lebeau, Hanny Wassef, Jae Hyun Byun, et al.
Microbiology (Reading, England)|May 15, 2025
Promoting global collaboration to improve bioaerosol exposure assessment and understanding of associated health impacts: outcomes from a series of workshopsEmma L Marczylo, Simon Jackson, Christine Bell, et al.
The Journal of Animal Ecology|August 18, 2022
Signatures of increasing environmental stress in bumblebee wings over the past century: Insights from museum specimensAndres N Arce, Aoife Cantwell-Jones, Michael Tansley, et al.
Pageof 7